What’s Going On With Priveterra, AEON Biopharma Shares Today?
Priveterra Acquisition Corp (NASDAQ: PMGM) on Monday announced the closing of its business combination with AEON Biopharma.
Priveterra Acquisition Corp. Announces Completion Of Business Combination With AEON Biopharma, Inc.
Priveterra Acquisition Corp. (NASDAQ:PMGM) ("Priveterra"), a special purpose acquisition company led by Chairman & CEO, Robert Palmisano, along with President, Vikram Malik, and COO and CFO, Oleg
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
Dow Rises 50 Points; American Express Earnings Top Views
U.S. stocks traded higher this morning, with the Dow Jones gaining around 50 points on Friday.
Following the market opening Friday, the Dow traded up 0.14% to 35,275.55 while the NASDAQ rose 0.52% to 14,135.92. The S&P 500, also rose, gaining, 0.32% to 4,549.47.
Why Lucid Group Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Gainers
TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares surged 84.1% to $15.54 in pre-market trading after jumping over 15% on Friday. Superlatus, Inc. signed a binding letter of intent to be acquired by TRxADE HEALTH.
AEON Biopharma, Priveterra Acquisition Announce Filing Of S-4 Registration Statement For Proposed Business Combination
https://www.aeonbiopharma.com/2023/01/aeon-biopharma-and-priveterra-acquisition-corp-announce-filing-of-s-4-registration-statement-for-proposed-business-combination-2/
AEON Biopharma And Priveterra Acquisition Corp. Announce Filing Of S-4 Registration Statement For Proposed Business Combination
AEON Biopharma, Inc. ("AEON" or the "Company"), a clinical-stage biopharmaceutical company developing a proprietary botulinum toxin for the treatment of multiple debilitating medical conditions, and